Cargando…
Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125
Cancer antigen 125 (CA125) is a widely used biomarker in monitoring of epithelial ovarian cancer (EOC). Due to insufficient cancer specificity of CA125, its diagnostic use is severely compromised. Abnormal glycosylation of CA125 is a unique feature of ovarian cancer cells and could improve different...
Autores principales: | Bayoumy, Sherif, Hyytiä, Heidi, Leivo, Janne, Talha, Sheikh M., Huhtinen, Kaisa, Poutanen, Matti, Hynninen, Johanna, Perheentupa, Antti, Lamminmäki, Urpo, Gidwani, Kamlesh, Pettersson, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442799/ https://www.ncbi.nlm.nih.gov/pubmed/32826955 http://dx.doi.org/10.1038/s42003-020-01191-x |
Ejemplares similares
-
Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma
por: Terävä, Joonas, et al.
Publicado: (2019) -
Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022) -
Development of anti-immunocomplex specific antibodies and non-competitive time-resolved fluorescence immunoassay for the detection of estradiol
por: Leivo, Janne, et al.
Publicado: (2019) -
A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles
por: Islam, Md. Khirul, et al.
Publicado: (2019) -
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles
por: Islam, Md. Khirul, et al.
Publicado: (2023)